Jacques Donnez

What Is the Place of Myoma Surgery with the Advent of Selective Progesterone Receptor Modulators (SPRMs)

Uterine fibroids are the most common benign uterine tumors. This review examines the different management strategies, involving mainly surgery, and evaluates them in the light of new developments with selective progesterone receptor modulators. On the one hand, hysteroscopic and laparoscopic (or minilaparoscopic) myomectomy is the treatment of choice in women who wish to preserve their uterus, and hysterectomy has long been considered the standard surgical approach in symptomatic women who no longer wish to conceive. On the other hand, recent studies have demonstrated the efficacy of ulipristal acetate in the medical management of myomas. Analyzing the respective advantages of both medical and surgical therapy, we propose new guidelines for the management of fibroids that take into account the most important symptoms (bleeding, infertility) and the age of the patients.

Ovarian Tissue Freezing and Transplantation: Current Status

Purpose of Review To carefully evaluate a number of critical points related to ovarian tissue freezing and present factual data in terms of live birth rates and risks.

Uterine Fibroids and Infertility

Uterine fibroids (also known as leiomyomas or myomas) are the most common form of benign uterine tumors. Clinical presentations include abnormal bleeding, pelvic masses, pelvic pain, infertility, bulk symptoms, and obstetric complications.